X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (223) 223
diabetes (128) 128
female (110) 110
male (103) 103
endocrinology & metabolism (101) 101
hypoglycemic agents - therapeutic use (95) 95
type 2 diabetes (95) 95
middle aged (91) 91
aged (83) 83
diabetes mellitus, type 2 - drug therapy (78) 78
diabetes mellitus (76) 76
risk factors (76) 76
mortality (73) 73
abridged index medicus (61) 61
hyperglycemia (60) 60
insulin (58) 58
glucose (56) 56
risk (55) 55
cardiac & cardiovascular systems (54) 54
care and treatment (54) 54
heart failure (52) 52
medicine, general & internal (46) 46
cardiovascular disease (44) 44
drug therapy (44) 44
treatment outcome (44) 44
cardiovascular diseases (41) 41
insulin resistance (37) 37
blood glucose - metabolism (36) 36
peripheral vascular disease (36) 36
metformin (35) 35
adult (34) 34
blood glucose - analysis (34) 34
hospitalization (32) 32
clinical trials (31) 31
diabetes mellitus, type 2 - blood (31) 31
heart attacks (29) 29
mellitus (29) 29
research (29) 29
diabetes mellitus, type 2 - complications (28) 28
hypoglycemia (28) 28
health aspects (27) 27
hypoglycemic agents - adverse effects (27) 27
stroke (27) 27
patients (26) 26
complications and side effects (25) 25
dextrose (25) 25
hyperglycemia - drug therapy (25) 25
outcomes (25) 25
pioglitazone (25) 25
cardiovascular diseases - prevention & control (24) 24
diabetics (24) 24
hypoglycemic agents - administration & dosage (24) 24
therapy (23) 23
internal medicine (22) 22
prevention (22) 22
analysis (21) 21
diabetes therapy (21) 21
heart diseases (21) 21
insulin - therapeutic use (21) 21
risk assessment (21) 21
united states (21) 21
diabetes mellitus, type 2 - diagnosis (20) 20
diagnosis (20) 20
medicine & public health (20) 20
metformin - therapeutic use (20) 20
association (19) 19
double-blind (19) 19
hypoglycemic agents (19) 19
management (19) 19
myocardial infarction (19) 19
acute myocardial-infarction (18) 18
cardiovascular (18) 18
cardiovascular-disease (18) 18
diabetes mellitus - blood (18) 18
diabetes mellitus - drug therapy (18) 18
dosage and administration (18) 18
glucose control (18) 18
glucosides - therapeutic use (18) 18
glycemic control (18) 18
time factors (18) 18
death (17) 17
double-blind method (17) 17
randomized controlled trials as topic (17) 17
thiazolidinediones (17) 17
type 2 diabetes mellitus (17) 17
aged, 80 and over (16) 16
benzhydryl compounds - therapeutic use (16) 16
empagliflozin (16) 16
patient outcomes (16) 16
blood glucose - drug effects (15) 15
blood pressure (15) 15
cardiac patients (15) 15
cardiovascular diseases - mortality (15) 15
complications (15) 15
diabetes mellitus, type 2 - epidemiology (15) 15
follow-up (15) 15
glycated hemoglobin a - analysis (15) 15
hemoglobin (15) 15
intensive insulin therapy (15) 15
kidney diseases (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 6, pp. 542 - 550
This article reviews recommendations for diabetes screening, which vary with respect to whether and how to screen. The American Diabetes Association recommends... 
DEFINITION | CRITERIA | MEDICINE, GENERAL & INTERNAL | GLYCEMIA | A1C | MANAGEMENT | HEMOGLOBIN A(1C) | IMPAIRED GLUCOSE-TOLERANCE | RISK | CLASSIFICATION | MELLITUS | Diabetics | Care and treatment | Medical examination | Causes of | Diabetes | Diagnosis | Methods | Diabetes therapy | Hyperglycemia | Diabetes mellitus | Hemoglobin | Blood pressure | Glucose | Medical diagnosis | Patients | Insulin | Risk factors
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2006, Volume 355, Issue 18, pp. 1903 - 1911
A 53-year-old woman with asthma and multilobar pneumonia is admitted with respiratory failure. She is intubated and treated with antibiotics, albuterol, and... 
DIABETIC-PATIENTS | MORTALITY | MEDICINE, GENERAL & INTERNAL | INFECTIOUS COMPLICATIONS | INSULIN INFUSION PROTOCOL | TIGHT GLYCEMIC CONTROL | INPATIENT GLUCOSE MANAGEMENT | BLOOD-GLUCOSE | ACUTE MYOCARDIAL-INFARCTION | STRESS HYPERGLYCEMIA | WOUND-INFECTION | Case studies | Hyperglycemia | Hospitalization | Heart attacks | Diabetes | Glucose | Mortality
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 21, pp. 1995 - 2008
In this randomized, placebo-controlled trial, investigators evaluated the effects of the sodium–glucose cotransporter 2 inhibitor dapagliflozin in patients... 
NEPRILYSIN INHIBITION | OUTCOMES | COTRANSPORTER 2 INHIBITORS | MECHANISM | EMPAGLIFLOZIN | MEDICINE, GENERAL & INTERNAL | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Heart Failure - complications | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Combined Modality Therapy | Hospitalization | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Ventricular Dysfunction, Left - drug therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Measurement | Heart failure | Dapagliflozin | Patient outcomes | Physiological aspects | Cardiac output | Drug therapy | Testing | Intravenous administration | Renal function | Clinical trials | Hypoglycemia | Evidence-based medicine | Clinical outcomes | Sodium | Hemoglobin | Patient safety | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Ejection fraction | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Diabetologia, ISSN 1432-0428, 2018, Volume 61, Issue 10, pp. 2118 - 2125
...REVIEW Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits Beatrice C. Lupsa 1 & Silvio E. Inzucchi 1 Received: 4 April 2018 /Accepted... 
Type 2 diabetes | Human Physiology | Cardiovascular | Metabolic Diseases | Internal Medicine | Benefits | Review | Risks | Fractures | Medicine & Public Health | Renal | Ketoacidosis | SGLT2 inhibitors | RANDOMIZED CONTROLLED-TRIALS | ADD-ON | GLUCOSE COTRANSPORTER-2 INHIBITORS | CVD-REAL | ENDOCRINOLOGY & METABOLISM | PHASE-3 TRIAL | DOUBLE-BLIND | CARDIOVASCULAR MORTALITY | LOWERING DRUGS | EMPAGLIFLOZIN | REG OUTCOME TRIAL | Blood Pressure | Hypoglycemic Agents - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Body Weight | Kidney - drug effects | Risk Assessment | Sodium-Glucose Transporter 2 - metabolism | Cardiovascular Diseases - drug therapy | Humans | Diabetic Ketoacidosis - drug therapy | Randomized Controlled Trials as Topic | Neoplasms - complications | Canagliflozin - therapeutic use | Weight Loss | Bone and Bones - metabolism | Glucosides - therapeutic use | Ketosis - metabolism | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Medical colleges | Usage | Blood sugar | Development and progression | Kidney diseases | Dehydration (Physiology) | Risk factors | Kidneys | Diabetes mellitus | Body weight | Reabsorption | Glucose | Dehydration | Genitourinary tract | Cost-benefit analysis | Sodium | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2009, Volume 360, Issue 13, pp. 1346 - 1349
Journal Article
Journal Article
Journal Article
Diabetes care, ISSN 1935-5548, 2018, Volume 41, Issue 2, pp. 356 - 363
Journal Article